The only apparent paradox of the same degree of susceptibility of high- and low-CB1-expressing tumor cells to NK cell-mediated killing (Fig. 5) could be explained through the possible induction of other NK activating factors by SR141716 treatment. Here, CNR1 is linked to neoplasm.